Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



urinary incontinence2 - larry greenbaum1 - microrna1 - congenital defects1 - jevtana1 - bulbocavernosus reflex1 - meyer-weigert1 - concentrated urine1 - urinary excretion1 - benign prostate tissue1 - psa screening7 - stone disease prevention1 - national ambulatory medical care survey1 - renal replacement therapy1 - tumor metabolism1 - urethral valve1 - intravenous pyelography5 - bladder4 - intensity-modulated radiation therapy1 - proteins ralb1 - ohip1 - down's syndrome1 - critical care1 - chlamydia trachomatis2 - nsaids1 - primary care1 - mortality1 - antibiotic treatment1 - kidney abnormality1 - renal anemia1 -